Making Science Group Statistics

Total Valuation

BME:MAKS has a market cap or net worth of EUR 81.37 million. The enterprise value is 130.31 million.

Market Cap	81.37M
Enterprise Value	130.31M

Important Dates

The next estimated earnings date is Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:MAKS has 8.80 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.80M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.48%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.34
PB Ratio	8.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.22, with an EV/FCF ratio of -222.04.

EV / Earnings	-23.60
EV / Sales	0.57
EV / EBITDA	41.22
EV / EBIT	n/a
EV / FCF	-222.04

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 4.61.

Current Ratio	0.86
Quick Ratio	0.82
Debt / Equity	4.61
Debt / EBITDA	12.75
Debt / FCF	-67.81
Interest Coverage	-0.30

Financial Efficiency

Return on equity (ROE) is -41.53% and return on invested capital (ROIC) is -1.13%.

Return on Equity (ROE)	-41.53%
Return on Assets (ROA)	-0.46%
Return on Invested Capital (ROIC)	-1.13%
Return on Capital Employed (ROCE)	-2.08%
Revenue Per Employee	208,398
Profits Per Employee	-5,047
Employee Count	1,094
Asset Turnover	1.80
Inventory Turnover	64.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.57% in the last 52 weeks. The beta is 1.33, so BME:MAKS's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+5.57%
50-Day Moving Average	8.38
200-Day Moving Average	8.41
Relative Strength Index (RSI)	58.22
Average Volume (20 Days)	3,472

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:MAKS had revenue of EUR 227.99 million and -5.52 million in losses. Loss per share was -0.66.

Revenue	227.99M
Gross Profit	20.96M
Operating Income	-933,588
Pretax Income	-3.99M
Net Income	-5.52M
EBITDA	3.12M
EBIT	-933,588
Loss Per Share	-0.66

Full Income Statement

Balance Sheet

The company has 13.71 million in cash and 39.80 million in debt, giving a net cash position of -26.09 million or -2.97 per share.

Cash & Cash Equivalents	13.71M
Total Debt	39.80M
Net Cash	-26.09M
Net Cash Per Share	-2.97
Equity (Book Value)	8.63M
Book Value Per Share	1.04
Working Capital	-11.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 910,296 and capital expenditures -1.50 million, giving a free cash flow of -586,870.

Operating Cash Flow	910,296
Capital Expenditures	-1.50M
Free Cash Flow	-586,870
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is 9.19%, with operating and profit margins of -0.41% and -2.42%.

Gross Margin	9.19%
Operating Margin	-0.41%
Pretax Margin	-1.75%
Profit Margin	-2.42%
EBITDA Margin	1.37%
EBIT Margin	-0.41%
FCF Margin	n/a

Dividends & Yields

BME:MAKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.79%
FCF Yield	-0.72%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:MAKS has an Altman Z-Score of 2.1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.1
Piotroski F-Score	n/a